Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?
A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
- Sustainability and the bio/pharma supply chain
- Key finding: External stakeholders drive efforts
- Key finding: Supply-chain sustainability lags internal efforts
- Key finding: Measuring achievement a major challenge
- Key finding: Factoring sustainability into purchasing decisions
- Concluding thoughts
Sponsor: LGM Pharma
Links:
- Subscribe to our e-newsletter at www.dcatvci.org
- Follow us on Twitter @DCATvci
- Support the show
Support the show
Information
- Show
- Published31 March 2022 at 21:00 UTC
- Length15 min
- RatingClean